Second Dose Measles Vaccine Utilization and Associated Factors among Children Aged 24-36 Months in Western Guragae Zone, Central Ethiopia, 2024
| dc.contributor.advisor | Debela Gela | |
| dc.contributor.author | Fetiha Muzemil | |
| dc.date.accessioned | 2025-08-12T19:15:33Z | |
| dc.date.available | 2025-08-12T19:15:33Z | |
| dc.date.issued | 2024-05 | |
| dc.description.abstract | Background: Measles is a very contagious and terrible disease which causes serious illness in under-five children, but it can be easily prevented and controlled by vaccination. Even if, Ethiopia launched measles second dose vaccine (MCV2) in 2019, only 9.1% of children aged 24–35 months received the second dose of the measles vaccine which is below the target. However little is known about the utilization and associated factors for MCV2 in the study area. Objective: To assess second dose measles vaccine utilization and associated factors among children aged 24-36 months in Western Guragae Zone, Central Ethiopia, 2024. Methods: A community-based cross-sectional study was employed on a total of 610 children, from February 19 to March 19, 2024. Data was refined, coded and entered in to Epi info-7 and exported to SPSS-21 for data cleaning and analysis. The associations between independent and dependent variables were analyzed by using bi-variate and multivariate logistic regression and AOR at 95% CI was used to identify factors significantly associated with MCV2 utilization at p value. Results: The overall MCV2 utilization was 45.2% (95% CI: 41.2-49.3). Maternal education of secondary and above (AOR, 10.15; 95% CI: 6.18, 16.67) and not return back without getting vaccination (AOR, 2.91; 95% CI; 1.83, 4.64) increased the odds of MCV2 utilization. In contrast, longer distance from vaccination center (AOR, 0.328; 95% CI: 0.198, 0.541) and long waiting time (AOR, 0.387; 95% CI: 0.24, 0.61) reduced the odds of MCV2 utilization. Conclusion and Recommendation: Second dose measles vaccination utilization in the study area was below the national target of 95%. Maternal education, distance from nearest vaccination center, return back without getting vaccination and waiting time for vaccination were identified as significant factors for MCV2 utilization. Therefore, in order to increase utilization of MCV2 there is a need to strengthen the defaulter tracing system to follow up the children who default after receiving MCV 1 and focusing interventions on the identified factors. Keywords: measles second dose vaccine; utilization; children‘s; Western Guragae Zone; Ethiopia | |
| dc.identifier.uri | https://etd.aau.edu.et/handle/123456789/6419 | |
| dc.language.iso | en_US | |
| dc.publisher | Addis Ababa University | |
| dc.subject | measles second dose vaccine utilization children‘s Western Guragae Zone Ethiopia | |
| dc.title | Second Dose Measles Vaccine Utilization and Associated Factors among Children Aged 24-36 Months in Western Guragae Zone, Central Ethiopia, 2024 | |
| dc.type | Thesis |